154117-13-2Relevant academic research and scientific papers
COMPOUND WITH ANTICANCER ACTIVITY
-
Paragraph 1621, (2021/01/29)
A compound having anticancer activity, or a pharmaceutically acceptable salt thereof is provided. Used is a compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof: (wherein, L1 and L2 are the same or different and each represents a group represented by one formula selected from the group consisting of formulas (A) to (F), and S represents a group represented by one formula selected from the group consisting of formulas (S1) to (S18)).
TRICYCLIC HETEROCYCLIC COMPOUNDS AS STING ACTIVATORS
-
Paragraph 1304-1306; 1310-1312, (2019/12/08)
The present application provides tricyclic heterocyclic compounds that activate the STING pathway to produce interferons, which are useful in the treatment of various diseases including infectious diseases and cancer.
AMINOALKYL-SUBSTITUTED N-THIENYL BENZAMIDE DERIVATIVE
-
Paragraph 0116, (2014/09/17)
[Problem] To provide a compound that has an intestinal phosphate transporter (NPT-IIb) inhibitory action and is useful as an active ingredient of an agent for treating and/or preventing hyperphosphatemia. [Means for Solution] The present inventors conduct
